Skip to content

Modulus 1091348P2Recalls & reported problems

Nuvasive, Inc. · Modulus TLIF-A, 9x11x34mm 8° · Class 2 · Implant

All models of Modulus (41)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00887517849496), received between Feb 19, 2025 and Feb 19, 2025 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 2 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Detachment of Device or Device Component1

Patient problems

  • Bacterial Infection1
  • Pain1
  • Wound Dehiscence1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 19, 2025Detachment of Device or Device Component; Detachment of Device or Device Component

    THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE LIB COMPLICATIONS STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2022 A PATIENT UNDERWENT A TWO LEVEL TRANSFORAMINAL LUMBAR INTERBODY FUSION PROCEDURE AT L4/5 AND L5/S1 WITH POSTERIOR FIXATION FROM T10 TO PELVIS. DURING THE PROCEDURE A SMALL DUROTOMY WAS ENCOUNTERED AT THE RIGHT L5-S1 HEMILAMINECTOMY SITE WHICH WAS REPAIRED WITH NUROLON AND SURASEAL. (B)(6) ON (B)(6) 2022, WHEN FINAL HEMOVAC DRAIN WAS REMOVED, INCREASE DRAINAGE FROM SITE WAS NOTED AND A TESTED SAMPLE OF FLUID WAS POSITIVE FOR TAU. SKIN SURROUNDING INCISION DEVELOPED BULLAE. MIDODRINE STARTED FOR PERIOPERATIVE HYPOTENSION. STOPPED ON POD 8 WITH THE PLAN TO RESTART HOME HORMONE SUPPLEMENT. PATIENT ENDORSED HER BLOOD PRESSURE IS HIGHER WHEN TAKING SUPPLEMENTS. PATIENT PLANS TO FOLLOW UP WITH PCP REGARDING HORMONES AND BLOOD PRESSURE MEDICATION. ON (B)(6) 2022, PATIENT CALLED IN TO NEUROSURGERY ON CALL SERVICE REPORTING SMALL AREA OF DEHISCENCE W/ YELLOW DRAINAGE. PATIENT SCHEDULED TO BE SEEN IN CLINIC ON (B)(6) 2023 VISIT SMALL DEHISCENCE W/ NO DRAINAGE. TREATED WITH KEFLEX, HOME HEALTH WOUND CARE W/ SILVER ALGINATE DRESSING. (B)(6). ON (B)(6) 2023, AT 6MO PO VISIT; PATIENT

    Patient problems: Pain

    MAUDE report 21415620 ↗
  • InjuryFeb 19, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE LIB COMPLICATIONS STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2022 A PATIENT UNDERWENT A TWO LEVEL TRANSFORAMINAL LUMBAR INTERBODY FUSION PROCEDURE AT L4/5 AND L5/S1 WITH POSTERIOR FIXATION FROM T10 TO PELVIS. DURING THE PROCEDURE A SMALL DUROTOMY WAS ENCOUNTERED AT THE RIGHT L5-S1 HEMILAMINECTOMY SITE WHICH WAS REPAIRED WITH NUROLON AND SURASEAL. (B)(6). ON (B)(6) 2022 WHEN FINAL HEMOVAC DRAIN WAS REMOVED, INCREASE DRAINAGE FROM SITE WAS NOTED AND A TESTED SAMPLE OF FLUID WAS POSITIVE FOR TAU. SKIN SURROUNDING INCISION DEVELOPED BULLAE. MIDODRINE STARTED FOR PERIOPERATIVE HYPOTENSION. STOPPED ON POD 8 WITH THE PLAN TO RESTART HOME HORMONE SUPPLEMENT. PATIENT ENDORSED HER BLOOD PRESSURE IS HIGHER WHEN TAKING SUPPLEMENTS. PATIENT PLANS TO FOLLOW UP WITH PCP REGARDING HORMONES AND BLOOD PRESSURE MEDICATION. ON (B)(6) 2022 PATIENT CALLED IN TO NEUROSURGERY ON CALL SERVICE REPORTING SMALL AREA OF DEHISCENCE W/ YELLOW DRAINAGE. PATIENT SCHEDULED TO BE SEEN IN CLINIC ON (B)(6) 2023 VISIT SMALL DEHISCENCE W/ NO DRAINAGE. TREATED WITH KEFLEX, HOME HEALTH WOUND CARE W/ SILVER ALGINATE DRESSING.

    Patient problems: Bacterial Infection; Wound Dehiscence

    MAUDE report 21414976 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page